The abstract is read at the publisher; the summary is JClub's.
Fecal microbiota transplantation in diabetic osteoporosis models improves bone microarchitecture and restores lactate-MOESIN–TGF-β signaling, linked to reduced inflammatory and bone-resorption markers.
- Why it matters: Diabetic osteoporosis involves both disrupted bone homeostasis and immune dysregulation, but how gut microbial metabolism reshapes TGF-β–driven immune remodeling and bone protection is unclear.
- What they did: The work combined a pilot clinical safety/feasibility cohort with diabetic mouse models, using exploratory longitudinal BMD/serum biomarkers plus PBMC and splenic CD4+ T-cell transcriptomic context (GSE274561; GSE267853, CONT n=3, DM n=3). Replicated flow cytometry, RT-qPCR, Western blot, and perturbation experiments assessed Treg/Th17 balance and lactate-MOESIN–TGF-β/SMAD dysregulation.
- The result: In experimental DOP, FMT is associated with a restored Treg/Th17 balance and activation of lactate-MOESIN–TGF-β signaling, implying immune remodeling that supports bone protection.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.